Shanghai Baiqu Biomedical Technology Co., Ltd. announced that it has received $2,900,000 in funding led by Guangzhou Kingmed Diagnostics Group Co., Ltd. on January 3, 2023. The transaction included participation from Qiming Weichuang Venture Capital Management (Shanghai) Company Limited.